|
- 2017
BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK/p38 pathways without interfering with PDK1 activity in host cellsDOI: 10.1038/aps.2016.160 Keywords: BX-795, herpes simplex virus (HSV), Infected Cell Polypeptide 0 (ICP0), antiviral, JNK, p38 MAP kinase, PDK1, NF-kappaB Abstract:
|